Pacira gets FDA blessing for pain drug; Japan approves Parabolic's API production;

@FiercePharma:  Momenta wins injunction against rival Lovenox copy, thwarting Amphastar/Watson.  News | Follow @FiercePharma

> Pacira Pharmaceuticals won the FDA nod for its post-surgical pain drug Exparel. Release

> Nephron Pharmaceuticals plans a $313 million plant in South Carolina, aiming to add more than 700 jobs as the facility ramps up. News

> Indian API maker Parabolic Drugs won official accreditation from Japan's health regulators, allowing it to supply antibiotic products to Japanese drugmakers. Article

> U.K. proposals to allow pharmacists to alter prescriptions without consulting the prescriber are coming under some criticism. Item

> A fire at a Pfizer ($PFE) animal health research facility damaged several buildings and destroyed one hay barn. News

> Indian drugmakers worry that new pricing regulations on essential meds will favor foreign pharma companies. Report

> An Australian woman sued Merck's ($MRK) domestic unit, alleging that a Gardasil injection triggered her neurological problems. Story

> Vertex Pharmaceuticals ($VRTX) got three new price targets from analysts, with UBS assigning a $47 target, Piper Jaffray picking $63, and JMP Securities coming in between with $53. News

Biotech News

@FierceBiotech: Slideshow: 10 mobile apps in Life Sciences. Report | Follow @FierceBiotech

@JohnCFierce: Thanks to Bayer, Novo Nordisk, Glaxo, Spinifex and Imperial college for participating on academic/biotech panel at BioEurope. | Follow @JohnCFierce

@RyanMFierce: Obama steps up action on drug shortages with FDA mandate. News | Follow @RyanMFierce

@MaureenFierce: Happy Halloween! Check out our 2011 Biotech Graveyard report. Report | Follow @MaureenFierce

> Pacira stock surges after FDA nod for post-surgery pain drug Exparel. News

> VC drought for biotech hits hard in Europe with 44% drop in 3Q investment. Article

Biotech IT News

> Suspected anti-Parkinson's gene spotted in 23andMe database. Story

> PLoS tackles bioinformatics for beginners. News

> J&J links up with Foundation Medicine for cancer genomic test. Article

> McGill U. teams with eVision to speed clinical trial starts. News

> TrialReach rounds up $1.2M for online trial recruitment. Item

Medical Device News

> Stratatech gets $4.6M for skin substitute trial. News

> BD debuts AutoShield Duo. Story

> FDA OKs Gen-Probe HPV test. Report

> Occlutech scores another win against St Jude-AGA Medical. Item

> FDA OKs Medtronic study for Type 1 diabetes management. Article

> FDA panel gives AtriCure good news on Synergy system. Story

And Finally... Brain activity during dreams matches activity associated with similar movements in real life, a study found. Article

Suggested Articles

Look out, diabetes market: Novo Nordisk won its FDA nod for highly anticipated Rybelsus to control blood sugar in patients with Type 2 diabetes.

Insys is in fire sale mode as part of its bankruptcy plan, and now it’s been given the go-ahead to sell the opioid that helped get it there.

GSK CEO Emma Walmsley could soon have a new title: Microsoft board member. The software giant has nominated her to its board of directors.